Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/20615

Title:	Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.
Authors:	Villoslada, Pablo Rovira, Alex Montalban, Xavier Arroyo, Rafael Paul, Friedemann Meca-Lallana, Virginia Ramo, Cristina Fernandez, Oscar Saiz, Albert Garcia-Merino, Antonio Ramió-Torrentà, Lluís Casanova, Bonaventura Oreja-Guevara, Celia Muñoz, Delicias Martinez-Rodriguez, Jose Enrique Lensch, Eckart Prieto, Jose Maria Meuth, Sven G Nuñez, Xavier Campás, Clara Pugliese, Marco View more
Issue Date:	Oct-2015
Citation:	Neurol Neuroimmunol Neuroinflamm.2015 Oct;(2)5:e147
Abstract:	The aim of this study was to test the safety of diazoxide and to search for signs of efficacy in patients with relapsing-remitting multiple sclerosis (RRMS).
PMID:	26405686
URI:	https://hdl.handle.net/20.500.12530/20615
Rights:	openAccess
ISSN:	2332-7812
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Princesa > Artículos Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:

File	Description	Size	Format
PMC4567455.pdf		279.97 kB	Adobe PDF	View/Open